Announcement of Changchun Baike Biotechnology Co., Ltd. on the acceptance of the application for voluntary disclosure of the marketing license for the live attenuated nasal spray influenza vaccine

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.